On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review
Background: The amount a government should be willing to invest in adopting new medical treatments has long been under debate. With many countries using formal cost-effectiveness (C/E) thresholds when examining potential new treatments and ever-growing medical costs, accurately setting the level of...
Main Authors: | David Cameron, Jasper Ubels, Fredrik Norström |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-01-01
|
Series: | Global Health Action |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/16549716.2018.1447828 |
Similar Items
-
Evaluation of Clean Air from Viewpoint of Tile Industry Personnel
by: F Golbabaei, et al.
Published: (2002-09-01) -
Evaluation of Clean Air from Viewpoint of Tile Industry Personnel
by: F Golbabaei, et al.
Published: (2002-12-01) -
International experience in determining the cost-effectiveness thresholds
by: T. P. Bezdenezhnykh, et al.
Published: (2019-01-01) -
Cost-Effectiveness Analyses of Home Parenteral Nutrition for Incurable Gastrointestinal Cancer Patients
by: Wenqian Li, et al.
Published: (2022-05-01) -
Economic Evaluation of Coronary Heart Disease (CHD): Expectations and Challenges in UK and Iran
by: AD Parsa, et al.
Published: (2005-03-01)